Navigation Links
Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress
Date:9/26/2013

ROCKVILLE, Md., Sept. 26, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO, Richard Garr, will present at the Stem Cells & Regenerative Medicine Congress, on Monday, September 30 at 12:00 PM at the Hyatt Regency in Cambridge, MA (http://www.terrapinn.com/2013/stem-cells-usa-regenerative-medicine/index.stm). Mr. Garr will give an overview of Neuralstem's ongoing trial testing NSI-566 stem cells in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), now in Phase II, as well as a clinical progress update.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO )

In a separate presentation, ALS patient, Ted Harada, who received transplants in both his lumbar and cervical spinal regions in Phase I of the Neuralstem trial, will talk about his experience as a patient on Monday, September 30, at 9:00 AM.

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem's NSI-566 spinal cord-derived stem cell therapy is in an FDA-approved Phase II clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease. Neuralstem has been awarded orphan status designation by the FDA for its ALS cell therapy.

In addition to ALS, the company is also targeting major central nervous system conditions with its NSI-566 cell therapy platform, including spinal cord injury and isc
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neuralstem Updates ALS Stem Cell Trial Progress
2. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
3. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
4. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
5. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
6. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
7. Neuralstem Announces Proposed Public Offering
8. Neuralstem to Raise $7.0 Million in Registered Direct Offering
9. Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2013
10. Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
11. Neuralstem Secures $8 Million In Debt Financing From Hercules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 Sangamo BioSciences, Inc. (NASDAQ: ... release its second quarter 2015 financial results after the ... release will be followed by a conference call at ... public via telephone and webcast. During the conference call, ... discuss other business matters. The conference call ...
(Date:7/29/2015)... July 29, 2015  Depomed, Inc. (Nasdaq: DEPO ... for the quarter ended June 30, 2015. ... pain and neurology marketplace, with significant net product revenue ... value to our shareholders in both the immediate and ... Depomed. "Growth in the second quarter was led by ...
(Date:7/29/2015)... Fla. , July 29, 2015 The ... new balloon device called the ReShape Integrated Dual Balloon ... medications and surgery for people with obesity and one ... for Metabolic and Bariatric Surgery (ASMBS), the nation,s largest ... and gratified that after careful review the FDA has ...
Breaking Medicine Technology:Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 2Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 3Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 4Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 5Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 6Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 7Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 8Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 9Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 10Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 11Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 12Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 13Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 14Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 15American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3
... 15, 2011 Fuisz ( www.fuisz.com ) today announced ... for Permitting Stage Door Access to On-Line Vendor Information"). ... stated, "This patent covers a system that allows a ... access a product supplier database through the on-line vendor,s ...
... Perrigo Company (Nasdaq: PRGO ; TASE) today ... TEVA ) (previously Barr Laboratories Inc.) has begun shipping ... applicant to file a complete ANDA with a Paragraph IV ... with 180 days of generic exclusivity. The Hatch Waxman litigation ...
Cached Medicine Technology:Perrigo Announces Launch of the Generic Version of Nasacort® AQ 2Perrigo Announces Launch of the Generic Version of Nasacort® AQ 3
(Date:7/29/2015)... ... July 29, 2015 , ... In ... help with the problems of substance abuse that face today’s society, A Forever ... to come to their rehabilitation center. The facility, located in Southwest Michigan hosted ...
(Date:7/29/2015)... ... 29, 2015 , ... VideoLink , a leading provider ... in New York, NY, selected the ReadyCam on-site video studio to support their ... immediately access worldwide TV and cable news networks and participate in live TV ...
(Date:7/29/2015)... Plains, NJ (PRWEB) , ... July 29, 2015 , ... ... , Dr. Andrzej Klos, a board-certified pediatrician for nearly 38 years, is motivated each ... work, dedication and commitment to his profession shine alongside his many awards and accolades, ...
(Date:7/29/2015)... ... ... " Core Organizer ” was featured on NewsWatch as part of its monthly ... for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, ... get organized. , Wouldn’t it be great if everyone could be a little more ...
(Date:7/29/2015)... ... July 29, 2015 , ... The report ... for Atherosclerosis. Atherosclerosis is a slow, progressive disease that may start in childhood. ... first-in-class and best-in-class products. Complete report on Atherosclerosis Pipeline with 78 market data ...
Breaking Medicine News(10 mins):Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Get More Organized with the Core Organizer App 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... Associate ... MASON, Ohio, Nov. 28 Anthem Blue Cross ... $1.5 million to support,not- for-profit organizations in Ohio for ... "The generosity shown by our associates during this campaign ...
... 2007 to benefit LIFEbeat featuring items,from Madonna, Beyonce, Jack Nicholson, John Travolta, ... Out Boy, Yoko Ono, Jessica Biel, Jessica Alba, Jessica Simpson, Victoria ... Elijah Wood, Robin Williams, Hayden Panettiere, Joan Rivers & hundreds ... ...
... University of Illinois have uncovered a host of reasons for ... better brain function to improved immune responses. , Now a ... a link between moderate exercise and decreased inflammation of damaged ... that moderate exercise sped up how fast wounds heal in ...
... of regulating them are often inconsistent, incoherent and ultimately ... University of Utah scholars. , The book says that ... a consistent and coherent way of thinking about the ... to alternative and herbal remedies and supplements, sports-enhancing steroids, ...
... abuse research capacity of the University of Houston is ... to the Graduate College of Social Works Office of ... for the initiative comes from the National Institute on ... Institutes for Health (NIH). The funds will support the ...
... and 90 per cent would strongly encourage other people ... family member needed a transplant, according to a study ... issue of the UK-based urology journal BJU International. , ... only legal option, carried out detailed evaluations of 339 ...
Cached Medicine News:Health News:Anthem Blue Cross and Blue Shield Foundation and Plan Associates Pledge $2.2 Million to Community Organizations in 2008 2Health News:Largest Celebrity Memorabilia Auction Honors World AIDS Day 2Health News:Exercise may play role in reducing inflammation in damaged skin tissue 2Health News:Exercise may play role in reducing inflammation in damaged skin tissue 3Health News:Exercise may play role in reducing inflammation in damaged skin tissue 4Health News:Drugs and Injustice 2Health News:Drugs and Injustice 3Health News:Drugs and Injustice 4Health News:National Institutes of Health grant to fund drug abuse research at UH 2Health News:Live kidney donors report high satisfaction rates and minimal health problems 2Health News:Live kidney donors report high satisfaction rates and minimal health problems 3
Anatomically designed 3 cervical foam collar...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
Model C-10 is a four post cervical orthosis which controls flexion, extension, lateral flexion, rotation, and axial motion. Each post may be individually adjusted in height....
Foam Cervical Collar is medium-firm density. Breathable. Deeply anatomically contoured. Natural color, 100% cotton stockinette-covered for comfort. 2" hook and loop closures are another mark of quali...
Medicine Products: